These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25841943)

  • 1. Adverse cutaneous drug reactions--a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India.
    Qayoom S; Bisati S; Manzoor S; Sameem F; Khan K
    Arch Iran Med; 2015 Apr; 18(4):228-33. PubMed ID: 25841943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
    Chattopadhyay C; Chakrabarti N
    Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY; Lee CK; Choon SE
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
    Sharma VK; Sethuraman G; Kumar B
    J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2009 Jun; 58(3):227-30. PubMed ID: 20043529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
    Turk BG; Gunaydin A; Ertam I; Ozturk G
    Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse cutaneous drug reactions in a single quaternary referral hospital.
    Botelho LF; Porro AM; Enokihara MM; Tomimori J
    Int J Dermatol; 2016 Apr; 55(4):e198-203. PubMed ID: 26710962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
    Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
    Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of cutaneous drug eruptions in 200 patients.
    Patel RM; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18810845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
    Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
    Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
    Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
    Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
    Su P; Aw CW
    Int J Dermatol; 2014 Nov; 53(11):1339-45. PubMed ID: 25070588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cutaneous reactions to drugs in the setting of a general hospital.
    Grando LR; Schmitt TA; Bakos RM
    An Bras Dermatol; 2014; 89(5):758-62. PubMed ID: 25184915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of cutaneous drug eruptions in 200 patients.
    Raksha MP; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(1):80. PubMed ID: 18193504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia.
    Loo CH; Tan WC; Khor YH; Chan LC
    Med J Malaysia; 2018 Apr; 73(2):73-77. PubMed ID: 29703869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse cutaneous reactions to drugs among hospitalized patients: a one year surveillance].
    Danza A; López M; Vola M; Alvarez-Rocha A
    Rev Med Chil; 2010 Nov; 138(11):1403-9. PubMed ID: 21279253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
    Lee HY; Chou D; Pang SM; Thirumoorthy T
    Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.